ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
Director Dealing
Elixirr International plc (AIM: ELIX), an established, global award-winning challenger consultancy, announces that on 10 November 2022, the Company was notified that on that same day Simon Retter, a non-executive director of the Company, acquired a total of 12,621 ordinary shares of 0.005p each in the Company ("Ordinary Shares") at a price of 515 pence per Ordinary Share.
Following the purchase, Simon Retter's beneficial holding is 368,833 Ordinary Shares representing 0.80 per cent of the issued share capital of the Company.
For further Information please contact:
| Elixirr International plc
Stephen Newton, CEO
Graham Busby, CFO
|
| |
|
Public and Investor Relations contacts: Caroline Pitt
finnCap Ltd (Nominated Adviser & Sole Broker)
Christopher Raggett (Corporate Finance)
Alice Lane / Sunila De Silva (ECM)
|
investor-relations@elixirr.com
+44 (0)20 7220 0500 | |
|
| | |
About Elixirr International plc
Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.
Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Simon Retter | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Non-executive Director | ||||
| b) | Initial notification/Amendment | Initial Notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Elixirr International plc | ||||
| b) | LEI | 213800MKY7OHMVAKW681 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.005p each ("Ordinary Shares") | ||||
| Identification code | GB00BLPHTX84 | |||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information:
| 12,621 shares at 515p
| ||||
| e) | Date of the transaction | 10 November 2022 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM market (XLON) | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.